Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N4JA
|
|||
| Former ID |
DNCL002266
|
|||
| Drug Name |
CLT-008
|
|||
| Indication | Blood transfusion [ICD-11: QB98; ICD-10: Z51.3] | Phase 2 | [1] | |
| Company |
Cellerant Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02282215) Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.